Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

BACKGROUND: Viral relapse is a major concern in hepatitis C virus (HCV) antiviral therapy. Currently, there are no satisfactory methods to predict viral relapse, especially in the era of direct acting antivirals in which the virus often quickly becomes undetectable using PCR-based approaches that fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Peng, Xu, Yanjuan, Fried, Michael W., Di Bisceglie, Adrian M., Fan, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448998/
https://www.ncbi.nlm.nih.gov/pubmed/32847527
http://dx.doi.org/10.1186/s12879-020-05355-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448998/
https://www.ncbi.nlm.nih.gov/pubmed/32847527
http://dx.doi.org/10.1186/s12879-020-05355-2

Ejemplares similares